Literature DB >> 7540651

T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus.

Z W Chen1, Z C Kou, C Lekutis, L Shen, D Zhou, M Halloran, J Li, J Sodroski, D Lee-Parritz, N L Letvin.   

Abstract

Changes in T cell receptor (TCR) V beta repertoire and their correlation with virologic events were investigated in rhesus monkeys after acute infection with the simian immunodeficiency virus (SIV). 11 genetically defined rhesus monkeys were experimentally infected with SIVmac or a chimeric simian-human immunodeficiency virus (SHIV), and their peripheral blood lymphocytes (PBL) and lymph nodes were prospectively assessed for TCR V beta gene expression. PBL and lymph nodes of the acutely infected monkeys demonstrated an expansion of selected V beta-expressing T lymphocyte subpopulations as early as 3 d after infection. These expanded V beta-expressing lymphocyte subpopulations were comprised predominantly of CD8+ cells. Six of seven infected monkeys sharing a single electrophoretically defined major histocompatibility complex class I allele exhibited a similar expansion of V beta 14-expressing PBL. Sequence analyses of V-D-J segments of TCR-beta cDNA indicated that the V beta-expressing T cell subpopulation expansion can be oligoclonal. SIVmac-specific CD8+ cytotoxic T lymphocytes were demonstrated in both PBL and lymph nodes of the infected monkeys at the time expansion of the selected V beta-expressing cell subpopulations was seen. Finally, the expansion of the selected V beta-expressing lymphocytes in PBL coincided with the emergence and clearance of SIV p27 from the plasma of the infected monkeys. These results demonstrate that acute infection of rhesus monkeys with SIVmac or SHIV results in an expansion of CD8+ lymphocyte subpopulations expressing selected V beta gene families. The selectively expanded T lymphocytes may contribute to early viral clearance after acute SIVmac or SHIV infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540651      PMCID: PMC2192106          DOI: 10.1084/jem.182.1.21

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Molecular cloning of orangutan and gibbon MHC class I cDNA. The HLA-A and -B loci diverged over 30 million years ago.

Authors:  Z W Chen; S N McAdam; A L Hughes; A L Dogon; N L Letvin; D I Watkins
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

2.  Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins.

Authors:  J Li; C I Lord; W Haseltine; N L Letvin; J Sodroski
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

Review 3.  The simian immunodeficiency viruses.

Authors:  R C Desrosiers
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 4.  Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques.

Authors:  N L Letvin; N W King
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.

Authors:  S J Clark; M S Saag; W D Decker; S Campbell-Hill; J L Roberson; P J Veldkamp; J C Kappes; B H Hahn; G M Shaw
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

6.  Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag.

Authors:  Z W Chen; L Shen; M D Miller; S H Ghim; A L Hughes; N L Letvin
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

7.  Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.

Authors:  E S Daar; T Moudgil; R D Meyer; D D Ho
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

8.  Predominant use of a T-cell receptor V beta gene family in simian immunodeficiency virus Gag-specific cytotoxic T lymphocytes in a rhesus monkey.

Authors:  Z W Chen; H Yamamoto; D I Watkins; G Levinson; N L Letvin
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

9.  A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patients.

Authors:  J T Safrit; A Y Lee; C A Andrews; R A Koup
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

10.  The V beta 17+ T cell repertoire: skewed J beta usage after thymic selection; dissimilar CDR3s in CD4+ versus CD8+ cells.

Authors:  S Candéias; C Waltzinger; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  31 in total

Review 1.  The immunology of Epstein-Barr virus infection.

Authors:  D J Moss; S R Burrows; S L Silins; I Misko; R Khanna
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

2.  Combined megaplex TCR isolation and SMART-based real-time quantitation methods for quantitating antigen-specific T cell clones in mycobacterial infection.

Authors:  George Du; Liyou Qiu; Ling Shen; Probhat Sehgal; Yun Shen; Dan Huang; Norman L Letvin; Zheng W Chen
Journal:  J Immunol Methods       Date:  2005-11-15       Impact factor: 2.303

3.  Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire.

Authors:  Dirk Meyer-Olson; Kristen W Brady; Melissa T Bartman; Kristin M O'Sullivan; Brenna C Simons; Joseph A Conrad; Coley B Duncan; Shelly Lorey; Atif Siddique; Rika Draenert; Marylyn Addo; Marcus Altfeld; Eric Rosenberg; Todd M Allen; Bruce D Walker; Spyros A Kalams
Journal:  Blood       Date:  2005-12-01       Impact factor: 22.113

4.  Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection.

Authors:  J Mongkolsapaya; A Jaye; M F Callan; A F Magnusen; A J McMichael; H C Whittle
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

5.  The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia.

Authors:  G Pantaleo; J F Demarest; T Schacker; M Vaccarezza; O J Cohen; M Daucher; C Graziosi; S S Schnittman; T C Quinn; G M Shaw; L Perrin; G Tambussi; A Lazzarin; R P Sekaly; H Soudeyns; L Corey; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

Review 6.  Study of the T cell receptor repertoire in viral immunodeficiency disease.

Authors:  C Ciurli; R P Sékaly; H Soudeyns
Journal:  Springer Semin Immunopathol       Date:  1996

7.  Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection.

Authors:  G Pantaleo; H Soudeyns; J F Demarest; M Vaccarezza; C Graziosi; S Paolucci; M Daucher; O J Cohen; F Denis; W E Biddison; R P Sekaly; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

8.  Decreased levels of recent thymic emigrants in peripheral blood of simian immunodeficiency virus-infected macaques correlate with alterations within the thymus.

Authors:  Donald L Sodora; Jeffrey M Milush; Felecia Ware; Aneta Wozniakowski; Lisa Montgomery; Harold M McClure; Andrew A Lackner; Marta Marthas; Vanessa Hirsch; R Paul Johnson; Daniel C Douek; Richard A Koup
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Potent immune responses of Ag-specific Vgamma2Vdelta2+ T cells and CD8+ T cells associated with latent stage of Mycobacterium tuberculosis coinfection in HIV-1-infected humans.

Authors:  Lingyun Shao; Wenhong Zhang; Shu Zhang; Crystal Y Chen; Weimin Jiang; Yunya Xu; Chengyan Meng; Xinhua Weng; Zheng W Chen
Journal:  AIDS       Date:  2008-11-12       Impact factor: 4.177

10.  Extraction and characterization of the rhesus macaque T-cell receptor beta-chain genes.

Authors:  Hui Yee Greenaway; Monica Kurniawan; David A Price; Daniel C Douek; Miles P Davenport; Vanessa Venturi
Journal:  Immunol Cell Biol       Date:  2009-06-09       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.